The forward P/E compression to 16.9x is the most compelling finding; it implies that earnings are expected to rise sharply enough to justify a near‑term re‑rating, making the stock attractive for investors seeking upside from earnings acceleration rather than multiple expansion.
If JJSF fails to meet the implied 15% earnings growth required for the forward P/E of 16.9x, the valuation could revert toward its historical mean, potentially pushing the stock back up to a P/E above 35x and eroding the current discount.
| Metric | Historical DCF | Analyst DCF |
|---|---|---|
| Growth Assumption | 4.1% (10Y CAGR) | Analyst Rev × 5.0% margin |
| PV of FCF | $392.4M | $349.1M |
| Terminal Value (PV) | $2.41B | $2.05B |
| Enterprise Value | $2.81B | $2.40B |
| Equity Value | $2.75B | $2.34B |
| Implied Stock Price | $141.21 | $120.14 |
| Upside/Downside | +90.3% | +61.9% |
| WACC \ Growth | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 3.7% | $217 | $276 | $386 | $651 | $2245 |
| 4.7% | $148 | $173 | $209 | $266 | $371 |
| 5.7% | $112 | $125 | $142 | $166 | $201 |
| 6.7% | $89 | $98 | $108 | $120 | $137 |
| 7.7% | $74 | $80 | $86 | $94 | $104 |
| WACC \ Growth | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 3.7% | $184 | $235 | $328 | $553 | $1904 |
| 4.7% | $126 | $147 | $177 | $226 | $315 |
| 5.7% | $95 | $106 | $121 | $141 | $171 |
| 6.7% | $76 | $83 | $92 | $103 | $117 |
| 7.7% | $63 | $68 | $74 | $80 | $88 |
| Method | Implied Value | Upside/Downside | Basis |
|---|---|---|---|
| P/E (Peer) | $84.17 | +13.4% | Peer median P/E (19.2x) × Forward EPS ($4.38) |
| P/B (Peer) | $54.44 | -26.7% | Peer median P/B (1.41x) × Book Value per Share |
| EV/EBITDA (Peer) | $76.32 | +2.8% | Peer median EV/EBITDA (9.6x) × EBITDA - Net Debt |
| P/S (Peer) | $48.16 | -35.1% | Peer median P/S (0.76x) × Revenue per Share |
| DCF | $141.21 | +90.3% | Revenue × FCF Margin projection |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net